Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors

Clinical trial NCT06076135 · COMPLETED

Trial details

NCT number: NCT06076135
Sponsor: Chuangzhen Chen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Radiotherapy Immune Checkpoint Blockade Resistance to Immunotherapy

Start date: 2023-12-26
Primary completion: 2026-05-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.